Quantcast

Jefferson Reporter

Thursday, December 26, 2024

6 companies in cities within Shelby County received six inspections in Q1 2023

Webp guy3yrvoyjza3x92utpmthz4c774

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website

There were six companies in cities associated with Shelby County, Alabama, that received six FDA inspections in the first quarter of 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 100% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.

Most of the companies inspected at the time were involved in the Food and Cosmetics and Devices sectors. Both the Biologics and Drugs sectors sectors tied for second most common type.

All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Companies Located in Cities Within Shelby County and Their Inspection Results
Company NameArea of BusinessInspection DateResult
AI Metrics, Inc.Devices02/17/2023No Action Indicated (NAI)
Anil Rajendra, M.D.Devices01/27/2023No Action Indicated (NAI)
Eric Wallace, M.D.Drugs02/24/2023No Action Indicated (NAI)
HRCFG, LLCBiologics03/21/2023No Action Indicated (NAI)
Royal Cup, Inc.Food and Cosmetics02/09/2023No Action Indicated (NAI)
S-L Distribution Company Birmingham Warehouse, Inc.Food and Cosmetics01/04/2023No Action Indicated (NAI)

MORE NEWS